Follow
anne largeot
anne largeot
LIH
Verified email at lih.lu
Title
Cited by
Cited by
Year
The B-side of cancer immunity: the underrated tune
A Largeot, G Pagano, S Gonder, E Moussay, J Paggetti
Cells 8 (5), 449, 2019
1532019
Transcription intermediary factor 1γ is a tumor suppressor in mouse and human chronic myelomonocytic leukemia
R Aucagne, N Droin, J Paggetti, B Lagrange, A Largeot, A Hammann, ...
The Journal of clinical investigation 121 (6), 2361-2370, 2011
1342011
Tif1γ regulates the TGF-β1 receptor and promotes physiological aging of hematopoietic stem cells
R Quéré, L Saint-Paul, V Carmignac, RZ Martin, ML Chrétien, A Largeot, ...
Proceedings of the National Academy of Sciences 111 (29), 10592-10597, 2014
722014
Crosstalk between leukemia-associated proteins MOZ and MLL regulates HOX gene expression in human cord blood CD34+ cells
J Paggetti, A Largeot, R Aucagne, A Jacquel, B Lagrange, XJ Yang, ...
Oncogene 29 (36), 5019-5031, 2010
642010
A role for miR-142-3p in colony-stimulating factor 1-induced monocyte differentiation into macrophages
B Lagrange, RZ Martin, N Droin, R Aucagne, J Paggetti, A Largeot, ...
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1833 (8), 1936-1946, 2013
602013
Interplay between SOX7 and RUNX1 regulates hemogenic endothelial fate in the yolk sac
AJ Lilly, G Costa, A Largeot, MZH Fadlullah, M Lie-A-Ling, G Lacaud, ...
Development 143 (23), 4341-4351, 2016
372016
Diagnostic and therapeutic potential of extracellular vesicles in B-cell malignancies
E Gargiulo, PE Morande, A Largeot, E Moussay, J Paggetti
Frontiers in oncology 10, 580874, 2020
202020
Expression of the MOZ-TIF2 oncoprotein in mice represses senescence
A Largeot, FM Perez-Campo, E Marinopoulou, M Lie-a-Ling, V Kouskoff, ...
Experimental Hematology 44 (4), 231-237. e4, 2016
192016
Extracellular Vesicle Secretion by Leukemia Cells In Vivo Promotes CLL Progression by Hampering Antitumor T-cell Responses
E Gargiulo, E Viry, PE Morande, A Largeot, S Gonder, F Xian, N Ioannou, ...
Blood cancer discovery 4 (1), 54-77, 2023
182023
Intrinsic Resistance of Chronic Lymphocytic Leukemia Cells to NK Cell-Mediated Lysis Can Be Overcome In Vitro by Pharmacological Inhibition of Cdc42-Induced …
H Wurzer, L Filali, C Hoffmann, M Krecke, AM Biolato, J Mastio, ...
Frontiers in Immunology 12, 619069, 2021
182021
Trim33/Tif1γ is involved in late stages of granulomonopoiesis in mice
ML Chrétien, C Legouge, RZ Martin, A Hammann, M Trad, R Aucagne, ...
Experimental hematology 44 (8), 727-739. e6, 2016
152016
Method for the analysis of the tumor microenvironment by mass cytometry: application to chronic lymphocytic leukemia
S Gonder, I Fernandez Botana, M Wierz, G Pagano, E Gargiulo, A Cosma, ...
Frontiers in Immunology 11, 578176, 2020
132020
Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as a therapeutic strategy in CLL
A Largeot, V Klapp, E Viry, S Gonder, I Fernandez Botana, A Blomme, ...
Blood, The Journal of the American Society of Hematology 141 (26), 3166-3183, 2023
72023
Interleukin-27 potentiates CD8+ T-cell-mediated antitumor immunity in chronic lymphocytic leukemia
G Pagano, IF Botana, M Wierz, PM Roessner, N Ioannou, X Zhou, ...
Haematologica 108 (11), 3011, 2023
62023
The tumor microenvironment-dependent transcription factors AHR and HIF-1α are dispensable for leukemogenesis in the eµ-TCL1 mouse model of chronic lymphocytic leukemia
S Gonder, A Largeot, E Gargiulo, S Pierson, I Fernandez Botana, ...
Cancers 13 (18), 4518, 2021
62021
Symplekin, a polyadenylation factor, prevents MOZ and MLL activity on HOXA9 in hematopoietic cells
A Largeot, J Paggetti, J Broséus, R Aucagne, B Lagrange, RZ Martin, ...
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1833 (12), 3054-3063, 2013
52013
Protein Arginine Methyltransferase 2 is involved in the control of inflammatory processes in acute myeloid leukemia
C Sauter, T Morin, F Guidez, J Simonet, C Fournier, C Row, D Masnikov, ...
Cancer Research 84 (6_Supplement), 5588-5588, 2024
2024
Targeting mRNA translation aberrations: A novel approach for therapy in chronic lymphocytic leukemia
V Klapp, J Paggetti, A Largeot, E Moussay
Cancer Communications 43 (12), 1373, 2023
2023
S141: INHIBITION OF MYC TRANSLATION THROUGH TARGETING OF THE NEWLY IDENTIFIED PHB-EIF4F COMPLEX AS THERAPEUTIC STRATEGY INCHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
A Largeot, V Klapp, E Viry, S Gonder, IF Botana, A Blomme, M Benzarti, ...
HemaSphere 7, e52627ab, 2023
2023
P635: TARGETING THE ONE-CARBON METABOLISM AS NOVEL THERAPEUTIC STRATEGY IN CHRONIC LYMPHOCYTIC LEUKEMIA
E Viry, A Largeot, S Gonder, S Chemlal, N Kiweler, J Meiser, T Helleday, ...
HemaSphere 6, 533-534, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20